Secor Capital Advisors’s AbbVie ABBV Stock Holding History

Secor Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-30,404	Closed	-$2.79M	–	414
2018 Q2	$2.79M	Sell	30,404 -1,932	-6%	-$189K	0.24%	134
2018 Q1	$3.03M	Buy	+32,336	New	+$3.55M	0.25%	132
2015 Q4	–	Sell	-8,386	Closed	-$456K	–	519
2015 Q3	$456K	Buy	8,386 +486	+6%	+$31.6K	0.14%	252
2015 Q2	$531K	Sell	7,900 -9,982	-56%	-$652K	0.19%	192
2015 Q1	$1.05M	Buy	+17,882	New	+$1.08M	0.41%	47
2014 Q2	–	Sell	-15,927	Closed	-$819K	–	226
2014 Q1	$819K	Buy	+15,927	New	+$805K	0.4%	74

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Secor Capital Advisors's ABBV Position: Q3 2018 in Review

Secor Capital Advisors sold out of AbbVie (ABBV) in Q3 2018, closing a stake of 30,404 shares — an estimated $2.79M sold.

Secor Capital Advisors first reported a position in ABBV in Q1 2014 and held it in 6 quarters. The position peaked at $3.03M in Q1 2018. 1,956 funds tracked by Wall St. Rank hold ABBV as of Q3 2018.

Secor Capital Advisors reported no remaining AbbVie position as of Q3 2018 after selling out during the quarter.
Secor Capital Advisors sold 30,404 AbbVie shares in Q3 2018, an estimated $2.79M.
Secor Capital Advisors first reported a position in AbbVie in Q1 2014 and held it in 6 quarters.
Secor Capital Advisors's AbbVie position peaked at $3.03M in Q1 2018.
1,956 funds tracked by Wall St. Rank held AbbVie as of Q3 2018.

Based on Secor Capital Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.